Image Resources NL Overview
Data-quality flag on the input list: The ISIN supplied (CA45245E1097) has a Canadian "CA" prefix. It does not match this Australian no-liability company. The ASX-listed Image Resources NL trades under ISIN AU000000IMA1, which is the identifier used by market-data services. The supplied ISIN should be corrected in the master list.
What it is: Image Resources NL is a Perth-based, single-asset mineral sands producer. It mines and sells zircon-, titanium- and monazite-bearing heavy mineral concentrate from the 100%-owned Atlas mine, about 170 km north of Perth in Western Australia's North Perth Basin.
Track record: Its predecessor operation, Boonanarring, ran for about five years and produced roughly 1.17 Mt of HMC. It generated close to A$800M in gross revenue. That track record funded dividends and the debt-free build of Atlas.
Asset base: Image controls about 1,237 km² of mineral sands tenure and a total Mineral Resource of about 6.4 billion tonnes containing about 101 Mt of heavy minerals. This includes the very large McCalls and Mindarra Springs ilmenite deposits.
Optionality: It is also developing a hydrogen-based synthetic rutile process and a small gold project, Erayinia King (139 koz inferred).
Current state: The investment case is now defined by distress rather than growth: weak titanium-feedstock prices, a A$53M impairment, near-exhausted Atlas reserves, a prepayment facility owed to its Chinese offtakers, a CEO departure and a formal strategic review.
Market view: The market values the company at roughly A$20–25M.
What the company does
Image Resources is an exploration, development and production company focused on heavy mineral sands in Western Australia.
Production model. The company runs a "mine-and-concentrate" model:
-
Ore is dry-mined using excavators and trucks.
-
It is processed through a wet concentration plant (WCP) that separates the valuable heavy minerals from sand and clay.
-
The resulting HMC is trucked to port and shipped in bulk to offtake customers in China.
HMC composition. The HMC is a mixed product containing:
-
zircon;
-
rutile;
-
leucoxene;
-
ilmenite;
-
monazite, a rare-earth-bearing phosphate.
Image does not currently operate a mineral separation plant. Separation of the HMC into individual mineral products, and any downstream processing, is carried out by the customer.
Company's own description
In its CY2025 annual report and quarterly reports, the company describes itself in three ways:
-
an Australian mineral sands miner;
-
a producer and supplier of mineral sands and critical minerals (titanium dioxide feedstocks, zircon and monazite);
-
a company with a value-adding technology strategy built around upgrading ilmenite to synthetic rutile.
It refers to the end of Atlas mining as the close of its "Chapter 1". "Chapter 2" growth involves:
-
new mineral sands developments (Durack, Yandanooka, Bidaminna, McCalls);
-
mineral separation;
-
synthetic rutile production using hydrogen.
Business model and revenue model
| Dimension | Characterisation |
|---|---|
| Revenue type | 100% product sales (bulk HMC shipments). No service, subscription or licensing revenue. |
| Pricing | Market-linked. HMC prices reflect the contained zircon, TiO2 and monazite at prevailing market prices. Revenue per tonne was A$389/DMT in Q1 2026 and A$414/DMT in Q2 2026 (Q2 2026 Quarterly). |
| Customers | Two long-standing Chinese offtake partners. Shantou Natfort Zirconium & Titanium Co., Ltd holds a life-of-mine offtake. Billion Sunny Investment Limited is the other prepayment counterparty. Guangdong Orient Zirconic (OZC), linked to shareholder Orient Zirconic Resources (Australia), has historically also been an offtaker. |
| Credit risk mitigation | Letters of credit supporting each bulk shipment before loading (Boonanarring/Atlas model as described in 2024). Customer prepayments (e.g., US$2.75M advance received in Q2 2026 for a July 2026 shipment). |
| Financing linkage | A secured US$20M offtake HMC prepayment facility from Natfort and Billion Sunny. It is repaid by delivering about 25% of each shipment at no cost, with the remaining ~75% paid at market prices. Interest is 10% p.a., compounding monthly. |
| Logistics | Atlas HMC has been exported via Geraldton Port (first shipment, April 2025). One trade-press article states Bunbury Port, a discrepancy; the company's first-shipment release referenced Geraldton. |
Value chain position
Image sits at the upstream extraction and primary concentration stage of the titanium and zircon value chains.
Downstream steps performed by others:
Separation: into zircon, rutile, leucoxene, ilmenite and monazite. This is done by the customer, e.g., Natfort in China.
Upgrading of titanium feedstocks: Ilmenite is upgraded to synthetic rutile or chloride slag.
Pigment production: Feedstocks are converted into TiO2 pigment by chloride or sulphate processes.
Zircon processing: Zircon goes into ceramics (tiles and sanitaryware), zirconia and zirconium chemicals, refractories and foundry uses.
Rare earths: Monazite goes into rare-earth processing.
End-markets served (indirectly)
| End-market | Mineral | Demand driver |
|---|---|---|
| Ceramic tiles, sanitaryware | Zircon (opacifier) | Chinese and global construction, housing |
| Zirconium chemicals, zirconia | Zircon | Industrial, electronics, nuclear, dental |
| TiO2 pigment (paints, plastics, paper) | Rutile, leucoxene, ilmenite | Construction, consumer goods, GDP |
| Titanium metal / welding | Rutile | Aerospace, defence, welding rods |
| Rare-earth magnets | Monazite (NdPr) | EVs, wind turbines, electronics |
| Abrasives (potential) | Garnet | Waterjet cutting, blasting. Image began screening garnet from HMC in Q2 2026 and held 1,387 DMT at 30 June 2026. |
Independent characterisation
Image is best described as a micro-cap, single-mine, price-taking concentrate producer. Its economics are almost entirely determined by four factors:
-
zircon and titanium-feedstock prices;
-
the AUD/USD exchange rate;
-
ore grade;
-
diesel and haulage costs.
Strengths. Its historical strength was operational. It delivered Boonanarring and Atlas on time and without external equity. Its customer concentration in two Chinese buyers provided reliable offtake and financing.
Weaknesses. The same concentration now gives the offtakers considerable leverage. The company sells a mixed concentrate rather than separated products, so it captures a smaller share of value than integrated peers such as Iluka.
Valuation. The company's large resource base (McCalls, Mindarra Springs, Bidaminna) has strategic value for a well-funded consolidator. However, it is largely un-monetisable on Image's own balance sheet.
Strategy
Stated strategy (themes from the CY2025 Annual Report and quarterly reports)
"Chapter 1": one mine, one product, one customer: Management credits this model with making Image an operator and funding dividends. It also concedes the model is not sustainable long-term. Atlas is the final stage of Chapter 1.
"Chapter 2" growth strategy: Its components are:
-
advancing studies on further mineral sands projects (Durack, Yandanooka, Bidaminna, McCalls, Mindarra Springs);
-
building a mineral separation plant;
-
upgrading ilmenite to synthetic rutile with a hydrogen-based, lower-CO2 process.
De-risking through multiple pipeline options: Pursuing several projects in parallel mitigates permitting and timing risk. Private-land projects (Durack, Yandanooka) carry lower environmental and heritage sensitivity than crown-land projects.
Disciplined, self-funded development: Atlas was built without an equity raising.
Initiatives in the last 24 months
| Date | Initiative | Detail / target |
|---|---|---|
| Aug 2024 – Apr 2025 | Atlas construction and ramp-up | Nameplate reached in CY2025; cash-cost guidance beaten |
| Aug 2025 | Post-Atlas pipeline program | Atlas North, Hyperion, Helene as satellite feed. Eneabba projects as new centres. |
| Sep 2025 | SR demonstration plant grant application | WA IAF New Energy Industries Round 2. Decision delayed past Q2 2026. |
| Oct 2025 | Cost reduction plus sales guidance alignment with offtakers | Prepayment repayment extended to 30 Apr 2026 |
| Jan 2026 | Gold diversification | Erayinia King maiden MRE (139 koz); strategic review of gold tenements |
| Mar 2026 | Balance-sheet relief | Six-month prepayment repayment holiday |
| Mar 2026 | Gold preliminary study | Completed 26 Mar 2026 |
| Q2 2026 | Product quality initiative | Garnet screening to upgrade HMC (+6.5% A$/t; lower haulage) |
| Q2 2026 | Durack capex reduction | Evaluating related-party pre-owned plant for Durack and Yandanooka |
| Q2 2026 | Boonanarring rehabilitation cost reduction | Mobile conveyor trial to backfill overburden (delayed) |
| Apr–Jul 2026 | Erayinia King drilling | 4,646 m to upgrade the resource and support a PFS in Q1 2027 |
| 20 Aug 2026 | Strategic review of assets | Optimise value, including possible monetisation of undervalued assets. Non-dilutive funding preferred. Preliminary stage; no decisions. |
| 20 Aug 2026 | Cost optimisation program | Corporate overhead and operating costs |
| 10 Sep 2026 | Durack resource upgrade | +43% resources; zircon 14% → 17% of HM; economic evaluation later in 2026 |
Management guidance (CY2026, Q2 2026 Quarterly)
| Metric | Guidance | YTD 30 Jun 2026 |
|---|---|---|
| HMC production (k DMT) | 170–190 | 127.8 (71% of midpoint) |
| HMC sold (k DMT) | 180–200 | 127.3 |
| C1 cash cost (A$/DMT produced) | 300–360 | 301 |
| AISC (A$/DMT produced) | 370–430 | 374 |
Management flagged that H2 2026 production will be lower than H1 as Atlas nears the end of its reserves. Atlas Proved Reserves were only 3.4 Mt at 31 Dec 2025.
No medium-term financial targets (revenue, margin or ROIC) have been published.
Products & Services
Image sells physical mineral products only. The portfolio comprises products sold today and pipeline projects that would generate future products.
Products currently sold
| Product | Description | Key specifications | Customer | Status / year | Pricing |
|---|---|---|---|---|---|
| Atlas HMC (zircon–titanium–monazite concentrate) | Mixed heavy mineral concentrate from the Atlas WCP | Atlas Proved Ore Reserve (31 Dec 2025): 3.4 Mt at 9.3% THM. HM assemblage 10.1% zircon, 8.0% rutile, 5.5% leucoxene, 49% ilmenite, 0.8% monazite. Slimes 15%, oversize 5.3%. | Natfort (life-of-mine offtake); Billion Sunny | Production since Q1 2025; first sale April 2025 | Market-linked; A$414/DMT in Q2 2026 |
| Upgraded (garnet-screened) HMC | HMC with garnet screened out before stockpiling, raising ZrO2/TiO2 grade and lowering freight per unit of VHM | Haulage costs cut by ~A$165K in Q2 2026 | Same offtakers | Introduced Q2 2026 | Higher A$/t (Q2 +6.5% vs Q1) |
| Garnet (by-product) | Screened garnet stockpile | 1,387 DMT stockpiled at 30 June 2026 | Marketing options under investigation | Not yet sold | — |
Historical product
| Product | Description | Output | Years |
|---|---|---|---|
| Boonanarring HMC | High-grade, zircon-rich HMC; described as one of Australia's highest-grade zircon-rich mineral sands projects | ~1.17 Mt HMC; ~A$800M gross revenue | Late 2018 – late 2023 |
Development pipeline (future products)
| Project | Location | Resource / reserve | Study status | Planned product | Key economics |
|---|---|---|---|---|---|
| Atlas extensions (Atlas North, Hyperion, Helene) | Near Atlas, Dandaragan Shire | Hyperion 3.6 Mt at 8.3% THM (Indicated); Helene 13.1 Mt at 4.8% THM | Mining approvals required. Baseline surveys done at Atlas North. | HMC via existing Atlas WCP | Low capital; not publicly quantified |
| Durack | ~280 km north of Perth (Eneabba) | Sep 2026 MRE: 37.7 Mt at 2.2% THM (1.2% cut-off), 0.83 Mt contained HM. 32 Mt Measured at 2.3%, 3.9 Mt Indicated at 1.7%, 1.8 Mt Inferred at 1.6%. Zircon 17% of HM. | PFS targeted Q3 2026, now slipped to "later in 2026". Mining lease M70/1456 applied for 5 May 2026. | HMC (zircon/ilmenite/monazite) | Not yet published |
| Yandanooka | ~300 km north of Perth | Probable Reserve 30 Mt at 3.9% THM; HM 14% zircon, 27% leucoxene, 46% ilmenite | PFS April 2024. BFS deferred pending land access. | HMC | PFS capex A$50.3M, expected to rise ~A$22M to ~A$72M. NPV A$151M pre-tax; IRR 72%; 8.2 yrs; 1.04 Mt HMC. |
| Bidaminna | ~100 km north of Perth | Probable Reserve 123 Mt at 1.8% THM; MRE 109 Mt at 2.5% THM. ~85% of HM is SR-grade ilmenite/leucoxene. | PFS June 2023. BFS on hold. | HMC; potential SR feedstock | Pre-tax NPV8 A$192M; IRR 28%; 10.5 yrs; capex ~A$194M |
| McCalls | North Perth Basin | 3,610 Mt at 1.3% THM (48 Mt HM; ilmenite 79% of HM) | Concept study; potential 25+ year life | Ilmenite / SR feedstock | — |
| Mindarra Springs | North Perth Basin | 2,200 Mt at 1.6% THM (Inferred; 36 Mt HM) | Early stage; described as analogous to McCalls | Ilmenite / SR feedstock | — |
| Other dry-mining deposits | Drummond Crossing, Ellengail, Robbs Cross, Thomson, Corridor, West Mine North, Gingin North/South, Regans Ford, Red Gully, Boonanarring NW/North Extension | See resource tables (Q2 2026 Quarterly) | Resource stage | HMC | — |
| Dredge deposits (Titan, Telesto, Calypso) | North Perth Basin | Titan 136.6 Mt at 1.9%; Telesto 3.5 Mt at 3.8%; Calypso 51.5 Mt at 1.7% | Resource stage | HMC | — |
| Synthetic rutile (SR) via hydrogen reduction | Proposed demo plant at Boonanarring | Novel process using hydrogen instead of coal as iron reductant | Under international patent review; grant application to WA IAF Round 2 pending | SR (high-grade TiO2 feedstock) | Funding-dependent |
| Mineral separation plant | Not sited | Would separate HMC into individual products | Concept | Zircon, rutile, ilmenite, monazite | — |
| Erayinia King gold | ~140 km SE of Kalgoorlie | 2.0 Mt at 2.1 g/t Au for 139 koz (Inferred, Jan 2026) | 4,646 m drilling completed (Apr–Jul 2026); PFS targeted early Q1 2027 | Gold doré (potential) | Preliminary metallurgy: >40% gravity-recoverable, >90% leach extraction of remainder |
Financial Narrative
Source for all tables: S&P Global Market Intelligence data as republished by StockAnalysis (income statement, balance sheet, cash flow) and TipRanks (FY2024 gross profit and EBITDA for FY2021–FY2024), consistent with the company's annual reports. FY2025 headline figures (revenue A$80.73M, net loss A$83.01M, total assets A$117.17M, equity A$14.63M, operating cash flow A$7.28M) match the FY2025 Annual Report filed in 2026.
Income statement
Notes:
-
FY2024 cost of revenue equals the TipRanks gross loss figure. StockAnalysis shows FY2024 revenue as "-" (nil) and FY2024 D&A of only A$0.20M. TipRanks shows FY2024 D&A of A$7.37M, so the two sources diverge.
-
FY2021–FY2024 EBITDA is from TipRanks/S&P. FY2025 EBITDA is derived as EBIT plus D&A.
-
The company guided to underlying Atlas EBITDA of about A$25M for CY2025, before rehabilitation and exceptional items (16 March 2026 announcement). The difference from the derived A$14.6M reflects corporate costs, rehabilitation and other items.
-
FY2025 net loss includes the ~A$52.2M impairment and the ~A$8M de-recognition of deferred tax assets, which explains why net loss exceeds pre-tax loss.
-
Cash dividends paid are shown instead. The FY2021 and FY2022 amounts imply roughly 1.9 and 1.2 cents per share (derived, approximate).
Margins and growth
Revenue CAGR FY2021–FY2025: −18.0% p.a. (derived). FY2024 margins and FY2025 growth are not meaningful because FY2024 revenue was nil.
Commentary:
FY2021–FY2022: the high-grade peak: Boonanarring delivered EBITDA margins of 34–38% on revenue of about A$170–180M. This was driven by:
-
high zircon grades;
-
the strong 2021–22 zircon price cycle;
-
a low-capex, contractor-run model. Cash generation (FY2021 operating cash flow A$74.7M) funded A$31.8M of dividends over two years and the A$24M Eneabba acquisition.
FY2023: depletion: Revenue fell 31% as Boonanarring wound down. Lower grades pushed gross margin to 16%, and a small impairment (A$2.2M) produced the first net loss.
FY2024: zero-revenue gap: With Boonanarring closed and Atlas under construction, the company had no sales. It absorbed care-and-maintenance costs, a A$15.1M operating loss and A$28.1M of capex.
FY2025: Atlas restart: Atlas restored revenue to A$80.7M within about eight months of first sale. However, it was barely gross-profitable on a statutory basis: a gross profit of A$0.16M after A$33.7M of D&A. Three factors explain this:
-
weak titanium-feedstock prices;
-
lower grades than Boonanarring;
-
accelerated depreciation of a short-life asset. A A$52.2M impairment and an A$8M tax-asset write-off took the net loss to A$83.0M. Seven-eighths of shareholders' equity was erased.
Balance sheet
Notes:
-
Short-term debt combines current debt and current leases. FY2024: 8.66 + 0.21. FY2025: 17.15 + 1.42.
-
Other long-term liabilities are predominantly provisions.
-
At 30 June 2026 (Q2 2026 Appendix 5B):
-
cash was A$12.98M, including US$5.18M on deposit;
-
loan facilities drawn (the prepayment facility) were A$12.74M;
-
insurance premium funding was A$0.83M;
-
a credit card facility of A$0.08M was outstanding.
-
Commentary:
From cash box to leverage: The balance sheet has moved from a cash-rich, debt-free position (A$79.8M net cash in FY2021) to net debt of A$12.3M at FY2025, with negative working capital of A$10.1M.
The prepayment facility: The US$20M facility was drawn in 2024–25 (A$8.0M in FY2024 and A$24.8M in FY2025). It is effectively customer-provided debt at 10% p.a., secured, and repaid in HMC.
Rehabilitation liabilities: These are about A$65M of "other long-term liabilities" and are large relative to equity of A$14.6M. Rehabilitation of Boonanarring (85 ha rehabilitated to date) and, in time, Atlas is a material future cash call.
H1 2026 movement: Cash improved to A$13.0M at 30 June 2026. Drivers were the debt repayment holiday, A$6.86M of proceeds from a property, plant and equipment sale in Q1 2026 (asset not identified), and positive Q2 operating cash flow.
Cash flow
Notes:
-
No buybacks appear in the cash flow statements.
-
FY2022 capex includes acquisition spending on the Eneabba and McCalls tenements. FY2024 and FY2025 capex is principally the Atlas build.
-
TTM to 30 June 2026: operating cash flow A$8.01M, capex A$13.79M, free cash flow −A$5.78M.
-
H1 2026 (Appendix 5B): operating cash flow A$1.54M; investing +A$3.81M (asset sale proceeds A$6.86M); financing −A$1.25M.
Ratios
All ratios are derived from the tables above. Methods:
ROE and ROA: average equity and average assets, except FY2021, which uses year-end balances because FY2020 balances were not captured.
ROIC: EBIT × (1 − 30%) divided by (equity + debt).
Cash conversion cycle: DSO + DIO − DPO, using year-end receivables, inventory and payables against revenue and cost of revenue.
- FY2024 net debt/EBITDA and cash conversion cycle are not meaningful (negative EBITDA, nil revenue) and are left blank.
Commentary:
Returns: These were attractive during the Boonanarring years (ROE 13–18%) and have since collapsed.
Liquidity: The FY2025 current ratio of 0.72x and debt/equity of 1.37x signal stress.
Stress relief: Two developments eased the position in H1 2026:
-
the repayment holiday, followed by the Billion Sunny extension to June 2027, which capitalises interest;
-
a stronger mid-2026 cash balance.
Cash conversion cycle: It is short because shipments are pre-financed by letters of credit and customer prepayments.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Boonanarring revenue (AUD Mn) | 119.13 | 0 | 0 |
Atlas revenue (AUD Mn) | 0 | 0 | 80.73 |
Group revenue (AUD Mn) | 119.13 | 0 | 80.73 |
Group gross profit (AUD Mn) | 19.26 | -7.37 | 0.16 |
Group operating income (AUD Mn) | -1.92 | -15.10 | -19.04 |
Group pre-tax income (AUD Mn) | -4.62 | -13.47 | -72.10 |
Group gross margin (%) | 16.2 | — | 0.2 |
Group operating margin (%) | -1.6 | — | -23.6 |
% of revenue from mineral sands HMC | 100 | 0 | 100 |
Revenue by Segment and Revenue by Segment (AUD)
| Metric | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
HMC produced (k DMT) | 55.9 | 73.0 | 69.0 | 59.2 |
HMC sold (k DMT) | 48.8 | — | 68.6 | 58.7 |
HMC revenue (AUD Mn) | — | — | 26.7 | 24.3 |
Revenue per tonne sold (A$/DMT) | — | — | 389 | 414 |
C1 cost (A$/DMT produced) | — | — | — | 331 |
AISC (A$/DMT produced) | — | — | — | 424 |
Closing cash (AUD Mn) | — | 7.7 | 10.0 | 13.0 |
Income Statement and Share Count (M)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (AUD Mn) | 178.85 | 171.54 | 119.13 | 0 | 80.73 |
Cost of revenue (AUD Mn) | 123.09 | 121.67 | 99.87 | 7.37 | 80.57 |
Gross profit (AUD Mn) | 55.76 | 49.87 | 19.26 | -7.37 | 0.16 |
SG&A (AUD Mn) | 25.24 | 22.16 | 14.43 | 6.74 | 16.06 |
Operating income / EBIT (AUD Mn) | 27.06 | 22.49 | -1.92 | -15.10 | -19.04 |
Depreciation & amortisation (AUD Mn) | 39.24 | 35.84 | 22.40 | 0.20 | 33.66 |
EBITDA (AUD Mn) | 67.75 | 58.83 | 18.33 | -5.65 | 14.62 |
Interest expense (AUD Mn) | 0.91 | 1.44 | 1.36 | 0.36 | 3.44 |
Asset write-down (AUD Mn) | 0 | 0 | 2.23 | 0 | 52.17 |
Pre-tax income (AUD Mn) | 27.32 | 21.56 | -4.62 | -13.47 | -72.10 |
Net income (AUD Mn) | 19.38 | 15.17 | -4.71 | -9.41 | -83.01 |
Weighted avg shares basic (M) | 998 | 1,060 | 1,080 | 1,110 | 1,110 |
EPS basic (A$ cents, derived) | 1.94 | 1.43 | -0.44 | -0.85 | -7.48 |
EPS diluted (A$ cents, derived) | 1.86 | 1.40 | -0.44 | -0.85 | -7.48 |
Dividends paid (AUD Mn) | 19.03 | 12.77 | 0.98 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 31.2 | 29.1 | 16.2 | — | 0.2 |
EBIT margin (%) | 15.1 | 13.1 | -1.6 | — | -23.6 |
EBITDA margin (%) | 37.9 | 34.3 | 15.4 | — | 18.1 |
Net margin (%) | 10.8 | 8.8 | -4.0 | — | -102.8 |
Revenue growth YoY (%) | 1.4 | -4.1 | -30.6 | -100.0 | — |
Balance Sheet and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 179.23 | 201.08 | 165.67 | 178.21 | 117.17 |
Cash & equivalents (AUD Mn) | 79.84 | 53.46 | 46.20 | 19.95 | 7.69 |
Inventory (AUD Mn) | 21.74 | 27.95 | 2.08 | 2.06 | 9.66 |
Property, plant & equipment (AUD Mn) | 68.96 | 107.05 | 99.12 | 141.17 | 90.96 |
Deferred tax assets (AUD Mn) | 0 | 4.53 | 10.40 | 10.92 | 0 |
Goodwill & intangibles (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Short-term debt incl. leases (AUD Mn) | 0.15 | 0.11 | 0.11 | 8.87 | 18.57 |
Long-term debt incl. leases (AUD Mn) | 0.17 | 0.09 | 0 | 1.02 | 1.44 |
Total debt (AUD Mn) | 0.32 | 0.20 | 0.11 | 9.88 | 20.00 |
Net debt (AUD Mn; negative = net cash) | -79.52 | -53.26 | -46.09 | -10.06 | 12.32 |
Other long-term liabilities incl. rehabilitation (AUD Mn) | 35.61 | 42.42 | 45.80 | 57.22 | 64.80 |
Total liabilities (AUD Mn) | 68.33 | 84.88 | 54.95 | 80.13 | 102.54 |
Shareholders' equity (AUD Mn) | 110.90 | 116.20 | 110.72 | 98.08 | 14.63 |
Working capital (AUD Mn) | 73.84 | 42.47 | 44.64 | 4.21 | -10.14 |
Book value per share (AUD) | 0.11 | 0.11 | 0.10 | 0.09 | 0.01 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | 74.73 | 36.80 | 14.08 | -6.30 | 7.28 |
Capital expenditure (AUD Mn) | -11.43 | -54.92 | -19.88 | -28.11 | -43.88 |
Free cash flow (AUD Mn) | 63.31 | -18.13 | -5.80 | -34.42 | -36.59 |
Dividends paid (AUD Mn) | -19.03 | -12.77 | -0.98 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Net debt issued / repaid (AUD Mn) | -17.17 | 0 | 0 | 7.73 | 23.89 |
Equity issued (AUD Mn) | 0.93 | 4.53 | 0 | 0 | 0 |
Cash income tax paid (AUD Mn) | 1.49 | 14.14 | 15.81 | -4.78 | 0 |
Net change in cash (AUD Mn) | 29.08 | -26.39 | -7.26 | -26.25 | -12.26 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%) | 17.5 | 13.4 | -4.2 | -9.0 | -147.3 |
ROA (%) | 10.8 | 8.0 | -2.6 | -5.5 | -56.2 |
ROIC (%) | 17.0 | 13.5 | -1.2 | -9.8 | -38.5 |
Current ratio (x) | 3.32 | 2.00 | 5.88 | 1.19 | 0.72 |
Debt to equity (x) | 0.003 | 0.002 | 0.001 | 0.10 | 1.37 |
Net debt to EBITDA (x) | -1.17 | -0.91 | -2.51 | — | 0.84 |
Interest coverage EBIT/interest (x) | 29.7 | 15.6 | -1.4 | -41.9 | -5.5 |
Asset turnover (x) | 1.00 | 0.90 | 0.65 | 0 | 0.55 |
Cash conversion cycle (days) | 39.6 | 55.9 | 11.6 | — | 6.3 |
Revenue by Region and Revenue by Region (%)
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
China – HMC revenue (AUD Mn, inferred) | 119.13 | 0 | 80.73 |
Australia – HMC revenue (AUD Mn) | 0 | 0 | 0 |
Rest of world – HMC revenue (AUD Mn) | 0 | 0 | 0 |
China share of revenue (%, inferred) | 100 | 0 | 100 |
Valuation Snapshot
| Metric | Value | Source / date |
|---|---|---|
Last price | A$0.019 | 9 Oct 2026 close |
2026 opening price | A$0.057 | InvestSMART |
YTD 2026 change | about −67% (derived) | — |
Price ~1 year ago | about A$0.062–0.065 (late Oct 2025) | InvestSMART release prices |
1-year change | about −70% (derived) | — |
1-year vs ASX 200 | −67.5% relative (as of mid-2026) | Market Index |
52-week range | A$0.02 – A$0.09 | Google Finance (Jul 2026) |
Metric | FY2021 | FY2022 |
Shares outstanding year-end (M) | 1,013 | 1,084 |
Book value per share (AUD) | 0.11 | 0.11 |
Net cash per share (AUD) | 0.08 | 0.05 |
Valuation Multiples
| Multiple | Image Resources | Comment |
|---|---|---|
Market cap | ~A$21.2M | 1,113.8M shares |
EV | ~A$21M | Cash A$13.0M and debt A$12.9M at 30 Jun 2026 roughly offset |
EV/EBITDA (FY2025 derived EBITDA A$14.6M) | ~1.4x | ~0.8x on company "underlying" A$25M. Optically cheap but reflects short Atlas life. |
EV/Sales (FY2025) | ~0.26x | — |
P/B (FY2025 equity A$14.6M) | ~1.4x | — |
Debt Facilities
| Facility | Amount | Rate | Maturity |
|---|---|---|---|
Offtake HMC prepayment facility (Natfort and Billion Sunny), secured, US$20M original | A$12.74M drawn | 10% p.a., compounding monthly | December 2026 per the Q2 2026 Appendix 5B. Billion Sunny portion extended to 30 Jun 2027 with interest capitalised (20 Aug 2026). Natfort portion under negotiation. |
Insurance premium funding (Ledge Finance) | A$0.83M | 7.38–7.9% | A$0.71M in Aug 2026; A$0.12M in Mar 2027 |
NAB corporate credit card | A$0.08M | — | Revolving |
Analyst Conclusions
Management guidance
CY2026 guidance is:
-
HMC production of 170–190k DMT;
-
sales of 180–200k DMT;
-
C1 of A$300–360/t;
-
AISC of A$370–430/t.
H1 2026 delivered 71% of the production midpoint, and H2 is guided lower. No guidance exists beyond CY2026, and there is no consensus because there is no broker coverage.
Bull case
-
Asset value far exceeds market value. About 101 Mt of contained HM, two PFS-stage projects (Yandanooka NPV A$151M; Bidaminna NPV8 A$192M) and a 139 koz gold resource sit inside a ~A$21M enterprise value. A strategic-review sale of the gold project or a non-core mineral sands asset could crystallise value.
-
Zircon recovery and Durack's zircon-rich assemblage. Zircon prices are rising (+10% in Q2 2026, further increases announced). Combined with Durack's 17% zircon share and possible related-party used plant, this could allow a low-capex follow-on mine as Atlas ends.
-
Patient creditor-shareholders. Offtakers and lenders have repeatedly extended terms without dilution. Strategic Chinese holders (~40% combined) have an incentive to keep the feedstock supply chain alive, potentially through further support or a takeover.
Bear case
-
Production cliff. Atlas reserves of 3.4 Mt imply mining ends in roughly 2027 or shortly after. No replacement project has a BFS, a mining lease, land access and funding all in place.
-
Balance-sheet fragility. Key indicators:
-
equity of A$14.6M;
-
about A$65M of rehabilitation-type liabilities;
-
negative working capital at FY2025;
-
10% secured customer debt. Together these mean equity holders could be heavily diluted or subordinated in any restructuring.
-
-
Weak economics at current prices. Titanium feedstock pricing remains weak, and FY2025 statutory gross profit was close to zero. Leadership turnover (CEO and CFO) during a strategic review raises execution risk.
Key catalysts and monitorables (next 12 months)
Q3 2026 Quarterly: (expected ~29 Oct 2026): production run-rate, cash, and resumption of repayments.
Natfort prepayment extension: Whether terms match the Billion Sunny deal (June 2027, capitalised interest).
Durack PFS / economic evaluation: ("later in 2026"); grant of mining lease M70/1456; land access agreements.
Related-party plant acquisition proposal: and any required shareholder vote.
Strategic review outcomes: Possible asset sales (gold or non-core sands) or a corporate transaction.
CEO appointment: and permanent CFO.
Erayinia King assays: (due end of Q3 2026) and PFS (early Q1 2027).
WA IAF Round 2 grant decision: on the SR demonstration plant.
Approvals for Atlas North and Hyperion: to extend Atlas life.
FY2026 Annual Report: (Mar 2027): further impairments, rehabilitation provisions, going-concern language.
Analyst verdict
What Image used to be. Image Resources NL is a company whose past is better than its present. Boonanarring was a textbook junior-miner success: built for about A$52M, it produced 1.17 Mt of high-grade concentrate and almost A$800M of revenue. It paid more than A$30M in dividends and funded a resource-acquisition spree in the Eneabba district and at McCalls.
What Atlas has delivered. Atlas was meant to bridge Image to "Chapter 2". Operationally it has done so: commissioning to first shipment took two months, nameplate was reached within the first half of operation, and cash costs have run at or below guidance in CY2025 and CY2026. Commercially it has fallen short. A lower-grade, ilmenite-heavy concentrate sold into a weak titanium market generated near-zero statutory gross profit in FY2025. That forced a A$53M impairment and an A$8M tax-asset write-off, leaving equity at A$14.6M.
Where the company stands now. Image is effectively in a managed transition under creditor forbearance:
-
its two Chinese offtakers hold secured prepayment debt at 10%;
-
both senior financial executives have left;
-
a strategic review is under way;
-
the only producing asset has about a year or two of reserves.
Valuation. The equity, at roughly A$21M, is priced as an option on three things:
-
continued offtaker support;
-
a low-capex Durack restart enabled by zircon price strength and pre-owned plant;
-
monetisation of non-core assets such as the Erayinia King gold project.
The resource base is genuinely large and strategically located. However, Image lacks the balance sheet to develop it, and the most likely value-realisation path is a transaction rather than organic development. That transaction could be a sale of assets, a farm-out, or control passing to strategic shareholders.
Verdict. We view the shares as a high-risk, event-driven special situation rather than an investment on fundamentals. Investors should anchor on liquidity and creditor terms first, then on Durack economics. They should also be prepared for dilution or corporate action. Absent a funded successor project by mid-2027, downside to the equity is substantial.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Independence | Notes |
|---|---|---|---|
Winston Lee | Non-Executive Chair; Executive Chair (interim) from 31 Aug 2026 | Not independent (executive since Aug 2026) | Assumed executive role on CEO transition. Prior roles, education and age not publicly disclosed in sources reviewed. |
Patrick Mutz | Managing Director & CEO (stepped down effective 31 Aug 2026) | Executive | Led Image through the Boonanarring build and operation, Atlas development, and the Eneabba and McCalls acquisitions. Held 8,309,188 shares (25 Jun 2026). Board status after 31 Aug 2026 not confirmed. |
Aaron Soo | Non-Executive Director | Independent | Details not publicly disclosed in sources reviewed |
Peter Thomas | Non-Executive Director | Independent | Details not publicly disclosed in sources reviewed |
Ran Xu | Non-Executive Director | Not independent | Details not publicly disclosed in sources reviewed. Believed associated with a major shareholder. |
Executive Leadership Team
| Name | Role | Tenure / status |
|---|---|---|
Patrick Mutz | MD & CEO | Departed 31 Aug 2026; replacement search under way |
Winston Lee | Executive Chair (interim) | From 31 Aug 2026 |
John McEvoy | CFO and Joint Company Secretary | Long-serving; retirement announced 3 Jun 2026, effective early Q3 2026 (~3 Jul 2026) |
David Lim | Interim CFO (engaged via The CFO Centre) | From Q3 2026 |
Major Shareholders
| Holder | Shares | % | Date of notice |
|---|---|---|---|
Murray Zircon Pty Ltd | 252,530,369 | 22.81 | 31 Mar 2026 |
Li Huang Cheng and Vestpro International Limited | 137,936,921 | 12.46 | 31 Mar 2026 |
Paradice Investment Management Pty Ltd | 61,215,970 | 5.52 | 29 Apr 2026 |
Orient Zirconic Resources (Australia) Pty Ltd | 54,453,343 | 4.92 | Most recent register data |
Patrick Mutz (director) | 8,309,188 | 0.75 | 25 Jun 2026 |
Competitive Landscape
Key Competitors
| Competitor | Listing | Relevance to Image | Comparative scale |
|---|---|---|---|
Iluka Resources | ASX: ILU | Largest Australian zircon/rutile/SR producer; Eneabba rare-earth refinery; WA neighbour | Large-cap; H1 2026 loss after tax A$24M; 2026 interim dividend 3 cents |
Tronox Holdings | NYSE: TROX | Vertically integrated TiO2 producer with WA mineral sands (Cooljarloo) near Image's tenure | — |
Rio Tinto Iron & Titanium (incl. Richards Bay Minerals) | ASX/LSE: RIO | Major zircon and titanium slag supplier | Global major |
Kenmare Resources | LSE: KMR | Moma (Mozambique) ilmenite/zircon producer | Mid-cap |
Base Resources (Kwale) / Energy Fuels | NYSE: UUUU | Mineral sands and monazite | — |
Strandline Resources | ASX: STA | — | Small-cap |
Sheffield Resources / Kimberley Mineral Sands (Thunderbird) | ASX: SFX | WA zircon/ilmenite producer; vendor of Image's Eneabba and McCalls assets | Small/mid-cap |
VHM Limited | ASX: VHM | Goschen (Victoria) rare-earth/mineral sands developer | Developer |
Astron Corporation | ASX: ATR | Donald (Victoria) mineral sands developer | Developer |
Chinese and African concentrate suppliers (e.g., Mozambique, Madagascar, Senegal producers) | Various | Compete for Chinese HMC and feedstock buyers | Various |
Peer Comparison FY2025
| Metric | Image Resources | Iluka Resources |
|---|---|---|
Latest annual revenue | A$80.7M (FY2025) | — |
Latest period result | FY2025 net loss A$83.0M | H1 2026 loss after tax A$24M |
Integration | HMC only | Separation, SR, rare earths |
Dividend | None since 2023 | 3c interim 2026 |
Recent Developments
Upcoming: the Q3 2026 Quarterly Report is expected around 29 October 2026 (Market Index calendar).



